AptarGroup Inc (ATR) Income Statement

An income statement shows a company's revenue, expenses, and profit over a reporting period.

AptarGroup, Inc. designs and manufactures drug delivery, consumer product dispensing, and active material science solutions and services for the pharmaceutical, fragrance, facial skincare, color cosmetics, personal care, home care, and food and beverage markets.

Total Revenue Chart for AptarGroup Inc

AptarGroup Inc (ATR) revenue for FY2025 was USD 3.8B, a 5.4% change from FY2024. AptarGroup Inc's revenue grew from USD 370.3M in 1992 to USD 3.8B in 2025 (920.0% over 33 years). Earnings per share grew from USD 0.89 in 2000 to USD 5.89 in 2025 (561.4%). Revenue compound annual growth rate: 5-year CAGR of 5.2%, 10-year CAGR of 5.0%, 20-year CAGR of 5.2%.

The most recent 8 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.

Total Revenue (US Dollars)

R&D as % of Revenue

Key Stats

Market Cap
$7.65B
Implied Share Price
$120.25
Enterprise Value
$9.15B
Revenue (TTM)
$3.93B
EBITDA
$798.40M
Profit Margin
9.22%
Trailing P/E
21.78
Forward P/E
19.76
Price/Book (MRQ)
3.02
Price/Sales (TTM)
1.94
EV/EBITDA
11.08
EV/Revenue
2.33
Dividend Yield
1.57%
Book Value
$41.33
Free Cash Flow (FY2025)
$299.58M
Free Cash Flow Yield
3.92%

Snapshot as of 7th October 2026 — not point-in-time controlled, may lag the live market by a few days.